CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Idorsia Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Idorsia Ltd
Hegenheimermattweg 91
ALLSCHWIL, 4123  Switzerland Ticker: IDIAIDIA

Business Summary
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Jean-PierreGarnier
Independent Non-Executive Chairman of the Board MathieuSimon 67 5/13/2020 5/3/2019
Director Robert J.Bertolini
17 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Idorsia Pharmaceuticals UK Ltd 20 EASTBOURNE TERRACE LONDON UNITED KINGDOM
Idorsia Pharmaceuticals Italy SRL LGO ANGELO FOCHETTI, 29 ROMA Italy

Business Names
Business Name
0RQE
IDIA
Idorsia Pharmaceuticals Deutschland GmbH
6 additional Business Names available in full report.

General Information
Number of Employees: 1,361 (As of 12/31/2022)
Outstanding Shares: 179,191,367 (As of 4/4/2024)
Stock Exchange: SWF


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024